Study drug for bladder pain compared with lidocaine, heparin, or placebo
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and willing to sign consent and follow study steps
- Have a diagnosis of IC/BPS for at least 9 months
- During screening, have pelvic pain/urgency score between 16 and 30 on the PUF questionnaire
- Have a bladder pain flare right before dosing (bladder pain score at least 5, and again 15 minutes after peeing)
- Have used a bladder “inside-the-bladder” pain-relief treatment before (a local anesthetic put directly into the bladder)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
This trial tests whether acupuncture can help relieve pain and pressure from bladder pain syndrome (also called interstitial cystitis). Researchers want to see if using acupuncture early can improve symptoms better than usual care.
This study tests a new treatment for women with interstitial cystitis (also called painful bladder syndrome) who have Hunner's lesions (specific sores in the bladder lining). The goal is to see if the new treatment can reduce pelvic pain, frequent urination, and other symptoms.
This early study tests a new medical system that measures pelvic and bladder pain patterns to help guide personalized botulinum toxin (BoNT) injections. It may help women with long-term bladder pain (interstitial cystitis/bladder pain syndrome) by improving how accurately treatment targets the pain source.
This trial tests a new nerve stimulation approach for women with bladder pain syndrome. It aims to find a gentler way to reduce pain and urgency without surgery.
Hear when a new Interstitial Cystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.